Chugai Pharmaceutical Co., Ltd. announced that Chugai Pharma Taiwan Ltd. (CPT), a wholly-owned subsidiary of Chugai, obtained an orphan drug import drug license from the Taiwan Food and Drug ...

| May. 17, 2025 04:30Since its founding in 1996, Royalty Pharma had operated under an external management model, relying on a separate Manager, owned by Pablo Legorreta and other members of senior ...

Mumbai: India’s pharmaceuticals sector, among the domestic industries most dependent on trade with the US, for now appears to have dodged the heavy reciprocal tariffs US President Donald Trump ...

TAIPEI, Taiwan, March 12, 2025 (GLOBE NEWSWIRE) -- At the ADC Asia Congress 2025 held today (3/12) in Singapore, OBI Pharma (4174.TWO) was honored with the "Most Promising ADC Clinical Candidate ...

Dr. Heidi Wang Accepts Award on Behalf of OBI Pharma at ADC Asia Congress 2025 and Gives a Presentation TAIPEI, Taiwan, March 12, 2025 (GLOBE NEWSWIRE) -- At the ADC Asia Congress 2025 held today ...

Senores Pharmaceuticals Ltd, a pharmaceutical formulations manufacturer that made its stock market debut in December last year, plans to focus on product acquisitions to expand its pipeline, a top ...

About Holling Bio-Pharma Corp. Headquartered in Taipei, Taiwan, Holling Bio-Pharma has been established for nearly five decades and is now the largest pharmaceutical distributor in Taiwan.

Daridorexant is a potential best-in-class treatment in the high-growth, dual orexin antagonist class of medicines treating sleep disorders, such as insomniaFiling of daridorexant in Taiwan planned ...

Dr. Makoto Sugita, CMO and President of Nxera Pharma Japan, commented: “This new partnership with Holling will enable us to bring daridorexant, a potential best-in-class treatment, to the growing ...

2025 might shape out to be a boon year for pharma, a recent report from Norstella’s Evaluate suggests. The 2025 Preview Report examines the “biggest movers and shakers” in the biotech and pharma ...

HAIKOU, China, Dec. 13, 2024 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," or the "Company"), a specialty pharmaceutical company, today announced that it has filed ...